Table 4 Frequency of HSP60, HSP70 and hnRNP L autoantibodies in human plasma
From: Effects of oxygen on the antigenic landscape of prostate cancer cells
Human plasma | HSP60 | HSP70 | HnRNP L | ||||||
|---|---|---|---|---|---|---|---|---|---|
N | mg/ml (mean ± SD) | Positive cases (% of total cases) | N | mg/ml (mean ± SD) | Positive cases (% of total cases) | N | OD (mean ± SD) | Positive cases (% of total cases) | |
Prostate cancer | 54 | 34.7 ± 43.9 | 7 (13 %); P < 0.05 compared to healthy controls | 38 | 21.8 ± 13.1 | 2 (5.3 %) | 38 | 0.267 ± 0.168 | 2 (5.3 %) |
Healthy control | 76 | 23.0 ± 25.8 | 1 (1.3 %) | 54 | 21.1 ± 11.8 | 2 (3.7 %) | 49 | 0.248 ± 0.117 | 3 (6.1 %) |
Colorectal cancer | 14 | 28.7 ± 25.5 | 1 (7.1 %) | 10 | 19.0 ± 8.8 | 0 (0 %) | – | – | – |
Lung cancer | 10 | 29.7 ± 34.4 | 1 (10.0 %) | 10 | 34.9 ± 42.2 | 2 (20 %) | – | – | – |
Renal cell carcinoma | 20 | 33.8 ± 24.2 | 1 (5.0 %) | 20 | 26.4 ± 19.0 | 1 (5.0 %) | – | – | – |
Rheumatoid arthritis | 17 | 21.5 ± 11.9 | 0 (0 %) | 17 | 61.5 ± 116.3 | 3 (17.6 %) | – | – | – |